# FDA Inspection 860634 - Medeast Post OP & Surgical - December 30, 2013

Source: https://www.keypedia.com/records/fda_inspections/medeast-post-op-surgical/42d65b0b-a448-49b5-8b89-36c52d2e2ef1
Source feed: FDA_Inspections

> FDA Inspection 860634 for Medeast Post OP & Surgical on December 30, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 860634
- Company Name: Medeast Post OP & Surgical
- Inspection Date: 2013-12-30
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 777697 - 2012-04-19](https://www.keypedia.com/records/fda_inspections/medeast-post-op-surgical/6294e028-57cc-48fa-b9d8-c8cb63bd45e2)
- [FDA Inspection 558929 - 2009-01-22](https://www.keypedia.com/records/fda_inspections/medeast-post-op-surgical/4dcb739a-c7fa-4497-bafb-afd61f57dd75)

Company: https://www.keypedia.com/companies/medeast-post-op-surgical/35acab23-7a70-4701-bfca-8c253950b51e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d